Cellular microparticle and thrombogram phenotypes in the Prospective Observational Multicenter Major Trauma

Nena Matijevic1, Yao-Wei W Wang1, Charles E Wade1

  • 1Center for Translational Injury Research and Division of Acute Care Surgery, Department of Surgery, Medical School, University of Texas Health Science Center at Houston, 6431 Fannin St. MSB 5.240, Houston, TX 77030, USA.

Thrombosis Research
|August 4, 2014
PubMed
Abstract

Insights

Trauma-induced coagulopathy is linked to altered cell microparticles (MPs) and reduced thrombin generation (TG). Lower tissue factor-bearing platelet MPs correlate with severe bleeding and mortality in trauma patients.

Area of Science:

  • Trauma and Hemostasis Research
  • Cellular Biology in Injury

Background:

  • Trauma-induced coagulopathy increases bleeding and mortality.
  • Injury alters cellular phenotypes, releasing procoagulant microparticles (MPs).
  • Circulating MPs support thrombin generation (TG) and clotting.

Purpose of the Study:

  • To evaluate MP and TG phenotypes in severely injured patients.
  • To correlate MP and TG phenotypes with coagulopathy and bleeding.

Main Methods:

  • Prospective Observational Multicenter Major Trauma Transfusion (PROMMTT) study.
  • Analyzed 180 trauma patients, 25 healthy controls, 40 minimally injured patients.
  • Assessed TG via Calibrated Automated Thrombogram and MP phenotypes via flow cytometry.

Main Results:

  • Coagulopathic patients showed significantly lower platelet MPs (PMP), tissue factor-bearing MPs (TFMP), and TG.
  • Elevated endothelial MPs (EMP), erythrocyte MPs (RMP), leukocyte MPs (LMP), and TFMP were observed in trauma patients compared to controls.
  • Coagulopathy was associated with higher bleeding and mortality.

Conclusions:

  • Cellular activation and enhanced TG are prevalent after trauma, independent of injury severity.
  • Coagulopathy is linked to lower thrombin peak and rate.
  • Reduced TF-bearing PMPs are associated with substantial bleeding.

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
156
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
6.9K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K